Propensity-matched comparison of microwave ablation and surgical resection for preoperative T1N0M0 papillary thyroid carcinoma: 5-year follow-up.

Background: Microwave ablation (MWA) has demonstrated short-term efficacy comparable to surgical resection (SR) for papillary thyroid carcinoma (PTC), but long-term data are limited.

Objective: To compare the long-term efficacy and safety of MWA versus SR in preoperative T1N0M0 PTC.

Materials And Methods: This single-center retrospective study included 792 patients with preoperative T1N0M0 PTC treated with MWA or SR from January 2016 to June 2019.

Risk Factors for Disease Progression in Thermal Ablation of Papillary Thyroid Cancer-A Large-sample Analysis.

Rationale And Objectives: This study aimed to analyze risk factors influencing disease progression in patients with papillary thyroid cancer (PTC) undergoing microwave ablation (MWA).

Materials And Methods: In this retrospective single-center study, 889 patients (647 women; median age, 40 years; age range, 14-80 years) who underwent MWA for PTC from June 2015 to December 2022 were enrolled. A least-absolute shrinkage and selection operator Cox regression model was employed to identify important factors for disease progression.

Efficacy and Safety of Thermal Ablation for Solitary Low-Risk T2N0M0 Papillary Thyroid Carcinoma.

Objective: To evaluate the efficacy and safety of thermal ablation in treating solitary low-risk T2N0M0 papillary thyroid cancer (PTC) and compare the outcomes of microwave ablation (MWA) and radiofrequency ablation (RFA).

Materials And Methods: This retrospective, single center study involved 34 patients (age: 40.0 ± 13.